# Allied Microbiota

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allied-microbiota

- Industry: Environmental Services
- Headquarters: New York, US
- Website: www.alliedmicrobiota.com
- Latest round: Seed (Sep 24, 2020)
- Investors on record: 2

## About

Allied Microbiota Inc specializes in innovative bioremediation solutions using effective bacterial strains to tackle environmental contamination challenges. The company is committed to promoting sustainable practices in soil and water decontamination.Founded in 2016 and headquartered in New York, US, Allied Microbiota Inc focuses on advanced bioremediation technologies. The company has successfully completed a funding round in September 2020, raising an undisclosed amount from IndieBio and SOSV. The founder’s history and previous ventures are not publicly available.Allied Microbiota focuses on advanced bioremediation solutions that utilize proven bacterial strains to address various environmental contamination issues. The company’s core product offerings include microbial treatments designed to decontaminate soils, sediments, water, and wastewater contaminated with hazardous substances such as petroleum products, poly-aromatic hydrocarbons, and chlorinated compounds. These products function by employing selected microbes that facilitate the breakdown of contaminants, aligning with regulatory compliance requirements. Among their notable innovations are bio-based treatments targeting emerging contaminants like per- and poly-fluoroalkyl substances (PFAS) and 1,4-dioxane. Allied Microbiota serves a diverse client base including industrial sectors, municipal water treatment facilities, and agricultural operations across North America and parts of Europe, effectively addressing their real-time decontamination needs while promoting sustainable practices.Allied Microbiota generates revenue through the sale of its bioremediation products and services, primarily targeting B2B partnerships with industrial clients and municipal governments. Transactions typically occur via direct sales agreements, where clients purchase microbial remediation solutions based on specific environmental challenges. The pricing structure for these products may vary depending on the scope of remediation required and the volume of contaminated material involved. The company’s flagship offerings, which include treatments for both traditional pollutants and emerging contaminants, are tailored to meet the regulatory standards necessary for environmental compliance. This strategic focus on regulatory alignment enhances Allied Microbiota's appeal to both existing and prospective customers concerned with sustainability and efficient waste management practices.Allied Microbiota aims to expand its product line with new bioremediation solutions designed to address additional contaminants, with plans to launch these offerings by late 2021. The company is also focusing on expanding its market presence in parts of Europe and Asia, specifically targeting the environmental remediation sectors in these regions by 2022. The funding raised in September 2020 will support the development of these new products and facilitate the expansion into new geographic markets.

## Funding rounds

- Seed, Sep 24, 2020 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed